Genus (LON:GNS – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at Berenberg Bank in a report issued on Wednesday, London Stock Exchange reports. They presently have a GBX 3,350 price target on the stock. Berenberg Bank‘s price target indicates a potential upside of 54.38% from the company’s previous close.
Genus Trading Down 3.9%
Shares of LON:GNS opened at GBX 2,170 on Wednesday. The company’s 50-day moving average price is GBX 2,246.44 and its two-hundred day moving average price is GBX 2,398.63. The company has a debt-to-equity ratio of 14.02, a current ratio of 2.22 and a quick ratio of 1.08. Genus has a one year low of GBX 1,943 and a one year high of GBX 3,220. The stock has a market capitalization of £1.40 billion, a PE ratio of 5.10, a price-to-earnings-growth ratio of 2.87 and a beta of 0.91.
Genus (LON:GNS – Get Free Report) last posted its quarterly earnings data on Thursday, September 10th. The company reported GBX 110.30 EPS for the quarter. Genus had a net margin of 43.35% and a return on equity of 44.90%. On average, equities analysts forecast that Genus will post 70.96 EPS for the current fiscal year.
Insider Buying and Selling at Genus
In other news, insider Jorgen Kokke sold 50,236 shares of the company’s stock in a transaction that occurred on Monday, September 14th. The stock was sold at an average price of GBX 2,151, for a total transaction of £1,080,576.36. 0.78% of the stock is owned by company insiders.
About Genus
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.
See Also
- Five stocks we like better than Genus
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.
